Product analysis
Lithium (Orotate) 20 mg is a single-ingredient supplement offered for mood support, though its expected benefit at supplement doses remains uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
Lithium is clearly identified as orotate, making the compound easy to distinguish. That identity alone does not establish an advantage in mood benefit or suitability.
Ingredient Transparency100
The lithium amount and orotate form are both listed. That makes comparison with other lithium supplements straightforward.
Value For Money40
The serving offers limited value on the available price comparison. A clearly named form does not by itself justify the cost.
Customer Satisfaction71
Customer feedback is strongly positive. The small review base leaves satisfaction less certain.
Product Focus82
The formula is focused on mood support, but evidence for monitored prescription lithium cannot be transferred to this supplement. The 20 mg serving exceeds the relevant comparison range without establishing greater benefit or suitability.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.58
- Customer rating
- 4.7 · 97 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Lithium (Lithium Orotate) | 20 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Lithium Compound Optimization
Dose, Safety & Label Transparency70
Elemental Disclosure Precision
Dosage Appropriateness
Value40
Cost Per Serving Efficiency
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
- GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
- A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
- Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
- A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.